Fanucci, K., Li, T., DeMeo, M., Kelly, E., Tolaney, S. M., Mayer, E. L., Tayob, N., Wolff, A. C., Krop, I. E., Jeselsohn, R. (2026). CAPELA: A phase II multicenter open-label randomized study of capecitabine in combination with elacestrant versus capecitabine alone in advanced estrogen receptor (ER)–positive breast cancer (TBCRC 070).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps1156